Suchergebnisse - "biological therapy"

PubPharm (3.926)

71

Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases : an observational study on the French National Health Data System

enthalten in: RMD open | 2024

von Jourdain, H. | Hoisnard, L. | Sbidian, E. | +1

72

Effectiveness and safety of adalimumab compared with leflunomide in patients with Takayasu arteritis : a retrospective cohort study

enthalten in: RMD open | 2024

von Peron Filho, F. | Moreira, A. | Janes, A. | +1

73

A retrospective multicenter case series of real-world tralokinumab use in dupilumab-experienced patients

enthalten in: JAAD case reports | 2024

von Herman, E. | Burgy, J. | Shahriari, M.

74

Influence of Prior Endoscopic Sinus Surgery Extent on Dupilumab Effectiveness in CRSwNP Patients

enthalten in: The Laryngoscope | 2024

von Alicandri-Ciufelli, M. | Marchioni, D. | Pipolo, C. | +10

75

Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer

enthalten in: Clinical colorectal cancer | 2024

von Patel, R. | Negassa, A. | Tolu, S. | +2

76

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

enthalten in: Seminars in arthritis and rheumatism | 2024

von Christiansen, S. | Horskjær Rasmussen, S. | Pons, M. | +30

77

Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice

enthalten in: Lupus | 2024

von Frade-Sosa, B. | Salman-Monte, T. | Narváez, J. | +10

78

Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritis

enthalten in: Seminars in arthritis and rheumatism | 2024

von McDermott, G. | DiIorio, M. | Kawano, Y. | +10

79

Paradoxical Reaction and Parastomal Pyoderma Gangrenosum Emergence With Secukinumab Therapy

enthalten in: ACG case reports journal | 2024

von Zaher, A. | Castillo, M.

80

Multidisciplinary Decision-Making—ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)

enthalten in: Current allergy and asthma reports | 2024

von De Corso, E. | Pipolo, C. | Caminati, M. | +23